BhumikaJayantibhaiPatelMD

PubMed

• Iptacopan for the treatment of paroxysmal nocturnal hemoglobinuria.
  Carlos M de Castro, Bhumika J Patel
  Expert Opinion on Pharmacotherapy. 2024-10-15
• Modified Delphi panel consensus recommendations for management of severe aplastic anemia.
  Daria V Babushok, Amy E DeZern, Carlos M de Castro, Zora R Rogers, David Beenhouwer
  Blood Advances. 2024-08-13
• 1 citations
  Paroxysmal nocturnal hemoglobinuria-related thrombosis in the era of novel therapies: a 2043-patient-year analysis.
  Carmelo Gurnari, Hussein Awada, Simona Pagliuca, Danai Dima, Fauzia Ullah
  Blood. 2024-07-11

Abstracts/Posters

• RORA Is a Potential Prognostic Biomarker and Therapeutic Target for Patients with Acute Myeloid Leukemia
  Bhumika J. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Extended Experience with a Very Low Dose, Metronomic, Subcutaneous Decitabine Regimen Intended to Deplete DNMT1 without Cytotoxicity
  Bhumika J. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Are Racial Disparities in Acute Myeloid Leukemia (AML) Clinical Trial Enrollment Associated with Comorbidities and/or Organ Dysfunction?
  Bhumika J. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• ANKRD26 Coding Variants Presenting with Giant Platelets and a Predisposition to Myeloid Neoplasia
  Bhumika J. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Effects of the Therapeutic Armamentarium on Survival and Time to Next Treatment in CMML Subtypes: An International Analysis of 950 Cases Coordinated By the AGMT Study ...
  Bhumika J. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• FA Gene Carrier Status Predisposes to Myeloid Neoplasms and Bone Marrow Failure in AdultsClinically Relevant Abstract
  Bhumika J. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Personalized Prediction Model to Risk Stratify Patients with Acute Myeloid Leukemia (AML) Using Artificial Intelligence
  Bhumika J. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Mutational Type and Configuration of an Individual Gene May Differentially Impact the Clinical and Phenotypic Features
  Bhumika J. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Determinants of Fitness for Intensive Therapy Among Acute Myeloid Leukemia (AML) Patients
  Bhumika J. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Identifying Factors That Predict for Unplanned Readmissions for Acute Myeloid Leukemia Patients Receiving Consolidation Cytarabine Based Therapies
  Bhumika J. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Eltrombopag Creates a Transient Chemical Phenocopy of TET2 Loss of Function That Contributes to Hematopoietic Precursor ExpansionClinically Relevant Abstract
  Bhumika J. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Large Granular Lymphocytic Leukemia Coexists with Clonal Hematopoiesis of Indeterminate PotentialClinically Relevant Abstract
  Bhumika J. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all